LaurenGugginaMD

Dermatology • Boston, MA

Physician

Join to view full profile

Dr. Guggina is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Guggina's full profile

Already have an account?

Office
221 Longwood Ave
Boston, MA 02115

Education & Training

McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine/Dermatology, 2012 - 2017
Indiana University School of MedicineClass of 2012

Certifications & Licensure

MA State Medical License 2020 - 2026
IL State Medical License 2017 - 2020
American Board of Dermatology Dermatology
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Combined topical 5-fluorouracil and calcipotriene effectively treats superficial keratinocyte carcinomas: A retrospective cohort study from 2 academic centers.
Nicole Loranger, Fatima N Mirza, Truelian Lee, Ethan Lowder, Emily Karn
Journal of the American Academy of Dermatology. 2024-11-10
Narrow-Band UVB Phototherapy in the Treatment of Cutaneous Immune-Related Adverse Events From Immune Checkpoint Inhibitors: A Multicenter Retrospective Analysis.
Jenny Lai, Lauren M Guggina, Connie R Shi
Photodermatology, Photoimmunology & Photomedicine. 2024-11-01
2 citations
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner
Journal for Immunotherapy of Cancer. 2024-04-10

Press Mentions

Meta-Analysis Reveals High Risk for Cutaneous AEs with PI3K InhibitorsOctober 18th, 2022